AstraZeneca shares rise on early U.S. approval for leukemia drug

Credit: Reuters India- Published 3 weeks ago
AstraZeneca shares rose 2.7% on Friday after the British drugmaker won earlier-than-expected U.S. regulatory approval for a leukemia drug, in a challenge to rival AbbVie .

You are here

Recent related videos from verified sources

Jim Cramer's Thoughts on Biogen's Alzheimer's Drug 00:48
Credit: The Street - Published on October 22, 2019 

You might like